Emerging developments in immune checkpoint inhibitor therapy for gastroenteropancreatic neuroendocrine neoplasm
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 3
Abstract
Immunotherapies targeting immune checkpoints have undergone rapid evolution, and have been preliminary explored in treatment of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) in recent years. However, their potential to deliver tangible clinical benefits remains uncertain. In this article, we systematically reviewed the current status and efficacy of clinical trials, which evaluated immune checkpoint inhibitor (ICI) as monotherapy or in dual-ICI therapy for GEP-NEN. Despite lacking substantial breakthroughs in GEP-NEN treatment, ICI demonstrated some antitumor activity and safety in treating recurrent or metastatic GEP-NEN, albeit with a generally low objective response rate (ORR). The ORR of ICI in GEP-NEN treatment exhibited a negative correlation with tumor differentiation, suggesting that poorly diffe-rentiated gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) might achieve better clinical responses. Disease control rate of dual-ICI therapy was higher than that of monotherapy. However, dual-ICI also got more severe side effects. Given the rarity of mismatch repair gene defects and high microsatellite instability (dMMR/MSI-H) in GEP-NEN, patients with high tumor mutational burden (TMB-H≥10 muts/Mb) could get potentially benefit from ICI therapy. In the future, it is expected to further explore the synergistic combined application of ICI with chemotherapy, radiotherapy, and antiangiogenic drugs in GEP-NEN, which may enhance its antitumor efficacy. Clinically, the benefit groups of ICI immunotherapy should be evaluated comprehensively according to pathological grading, immune markers, disease progression, and patient's physical condition.
Authors and Affiliations
Xu HAN, Wenquan WANG, Wenhui LOU, Liang LIU
Keywords
Related Articles
- EP ID EP750883
- DOI 10.16139/j.1007-9610.2023.03.015
- Views 12
- Downloads 0
Advances in minimally invasive surgery for thyroid tumors
The incidence of thyroid tumors has been increasing recent years, the importance of quality of life has been more concerned in addition to radical treatment. Traditional open surgery has been unable to meet the needs of...
Development and prospects of ERCP in China
Endoscopic retrograde cholangio-pancreatography (ERCP) is an interventional endoscopic technique aimed at the diagnoses and treatment of biliary and pancreatic diseases under the guidance of endoscopy and X-ray ima-ging....
Exosomes research in pathophysiology of peritoneal metastatic gastric cancer
Formation and improvement of surgery-based treatment system for gastric cancer
The treatment of gastric cancer is based on surgical resction. The accumulation of clinical research and in-depth understanding of tumor constitute the cornerstone of gastric cancer treatment. Development of surgical tec...
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in treatment of peritoneal metastatic gastric cancer: current status and future prospects